SJ, P., & EY, M. (2025). Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2. Biomolecules & therapeutics, 33(6), 1064. https://doi.org/10.4062/biomolther.2025.149
Chicago Style (17th ed.) CitationSJ, Park, and Moon EY. "Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2." Biomolecules & Therapeutics 33, no. 6 (2025): 1064. https://doi.org/10.4062/biomolther.2025.149.
MLA (9th ed.) CitationSJ, Park, and Moon EY. "Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2." Biomolecules & Therapeutics, vol. 33, no. 6, 2025, p. 1064, https://doi.org/10.4062/biomolther.2025.149.